Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
Children's Hospital of Philadelphia
Children's Hospital of Philadelphia
Stanford University
M.D. Anderson Cancer Center
Columbia University
Federal Research Institute of Pediatric Hematology, Oncology and Immunology